STUDY OF ANTITUMOR (PHASE-2) AND IMMUNOSUPPRESSIVE EFFECTS OF ICRF-159 IN PATIENTS WITH METASTATIC MELANOMA

被引:7
作者
BELLET, RE
CATALANO, RB
DANNA, VG
BERD, DA
BERKELHAMMER, J
MASTRANGELO, MJ
机构
[1] FOX CHASE CANC CTR,INST CANC RES,PHILADELPHIA,PA 19111
[2] AMER ONCOL HOSP,DEPT MED,PHILADELPHIA,PA
[3] TEMPLE UNIV,SCH MED,DEPT MED,PHILADELPHIA,PA 19140
关键词
D O I
10.1002/j.1552-4604.1976.tb02418.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:433 / 438
页数:6
相关论文
共 8 条
[1]  
BELLET RE, 1975, P AM ASSOC CANC RES, V16, P224
[2]  
BELLET RE, 1973, CANCER CHEMOTH REP 1, V57, P185
[3]   SEQUENTIAL INVITRO REACTIVITY OF LYMPHOCYTES FROM MELANOMA PATIENTS RECEIVING IMMUNOTHERAPY COMPARED WITH REACTIVITY OF LYMPHOCYTES FROM HEALTHY DONORS [J].
BERKELHAMMER, J ;
MASTRANGELO, MJ ;
LAUCIUS, JF ;
BODURTHA, AJ ;
PREHN, RT .
INTERNATIONAL JOURNAL OF CANCER, 1975, 16 (04) :571-578
[4]  
CREAVEN PJ, 1974, CANCER CHEMOTH REP 1, V58, P393
[5]  
DUKE DI, 1973, BIOMEDICINE, V18, P199
[6]  
MARCINIAK TA, 1975, CANCER CHEMOTH REP 1, V59, P761
[7]  
TUCKER DF, 1972, J NATL CANCER I, V48, P1347
[8]  
WOODMAN RJ, 1974, CANCER CHEMOTH REP 2, V4, P45